QR Code

Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), emerges as major cause of morbidity and mortality globally, with chronic patients facing increased risk. Guidelines on MASLD management in primary care (PC) are limited. This study aimed to develop and evalua...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Marilena Anastasaki, Sophia Papadakis, Irini N. Gergianaki, Loucas Papastamatiou, Eftychios Aligizakis, Nikoleta Grillaki, Eleni Boutzoukaki, Nektarios Sivaropoulos, Foteini Anastasiou, Juan Mendive, Carlos de Juan-Asenjo, Rosario Hernández-Ibáñez, Alba Martínez-Escudé, Montserrat Garcia-Retortillo, Ger Koek, Leen Heyens, Jean Muris, Christos D. Lionis
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Frontiers Media S.A. 2024-11-01
Rangatū:Frontiers in Medicine
Ngā marau:
metabolic dysfunction-associated steatotic liver disease (MASLD)
primary care
clinical care pathways
risk classification
non-alcoholic fatty liver disease (NAFLD)
screening
Urunga tuihono:https://www.frontiersin.org/articles/10.3389/fmed.2024.1383112/full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite